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tory failure. CTPA was done to rule out pulmonary embolism, which showed
no pulmonary embolism but bilateral gross consolidation, more on the right,
in keeping with an infective process. Antibiotics were changed to intrave-
nous Ceftriaxone and Azithromycin; however, there was continuous deterio-
ration and patient succumbed to his illness on day 4 of admission. His throat
swab was later traced back to be positive for MERS-CoV, while his sputum
was negative for bacterial cultures.PS 2-334
INFLUENZA A (H1N1) PNEUMONIA WITH ACUTE RESPIRATORY DISTRESS
SYNDROME (ARDS) AND RHABDOMYOLYSIS WITH ACUTE RENAL FAILURE:
A CASE REPORT
Mei-Chen Chen a, Wen-Liang Yu b, Chin-Ming Chen c. aDepartment of
Nursing, Chi Mei Medical Center, Yong Kang, Tainan City, Taiwan;
bDepartment of Intensive Care Medicine, Chi-Mei Medical Center, Tainan,
Taiwan; cDepartment of Intensive Care Medicine, Chi-Mei Medical Center,
Tainan, Taiwan
Purpose: It is generally noted that patients with pneumonia from pandemic
H1N1 may have abnormal laboratory examination results, including elevated
creatine kinase (CK) levels in the previous literatures. We herein report a
similar case complicated with ARDS and rhabdomyolysis.
Case report
This 36-year-old woman was admitted to our emergent room with fever for 2
days. She was transferred to the ICU due to influenza A pneumonia with ARDS
and profound hypoxemia. Immediate endotracheal intubation was done and
Nitrogen oxide (NO) was used for profound hypoxemia. Prone position
ventilation was not attempted due to morbid obesity. Antibiotic therapy
with Tazozin, Cravit and Tamiflu was used. Dopamine was prescribed due to
refractory shock post resuscitation. However, no significant bacterial culture
result was obtained, except a positive PCR for Influenza A (H1N1). The PaO2/
FiO2 ratio remained < 200 mmHg, requiring the use of high PEEP, fully
sedation and muscle relaxant to maintain the oxygenation. However, fever
and shock persisted, hence, Cravit was shifted to Tygacil. The subsequent
follow-up blood culture was negative. Poor oxygenation hindered her from the
study of Computed Tomography. Oliguria with tea-colored urine was noted.
Marked elevation of CK total [7601 IU/L] and myoglobin [32890 mg/dL] were
noted. Rhabdomyolysis with acute renal failure was impressed, which was
probably related to H1N1 infection. After the treatment, the condition was
still worsening. Due to unstable blood pressure and severe metabolic acidosis
with oliguria, continuous veno-veno hemofiltration (CVVH) was commenced.
Then the patient finally expired due to progressive condition.
Conclusions: Although pneumonia and ARDS are the most common severe
complications of H1N1 infection. Rhabdomyolysis should be considered in
the evaluation of muscle symptoms associated with Influenza A (H1N1) Pneu-
monia, especially in critically ill patients. Timely extra-corporeal membrane
oxygenation may be helpful to survive the patients with life-threatening
Influenza infection.PS 2-335
URINARY TRACT INFECTION CAUSED BY MYROIDES SPECIES: A CASE
REPORT
Mei-Yu Su a, Wen-Liang Yu a,b, Che-Kim Tan a. aDepartment of Intensive
Care Medicine, Taiwan; bChi-Mei Medical Center, Tainan City, Taiwan
Purpose: Myroides species are widely distributed in nature, but clinical hu-
man infections by these organisms are extremely rare. We report herein pro-
longed outbreak of urinary tract infection by Myroides species.
Case report
A 63-year-old male of end stage renal disease, rheumatoid arthritis,
destroyed lung post operation, post tracheostomy suffered from conscious-
ness change and much sputum for five days. He was brought to emergency
department on November 17, 2014. Laboratory data shows leukocytosis
(WBC: 13,300/mL); bandemia (band: 5%); and C-reactive protein, 113 mg/
L. CXR showed almost whiteout of the right side destroyed lung with residual
alveolar, surgical clips and suture stitches left. Ceftazidime was given. Brain
CT showed mild communicating hydrocephalus and mixed acute and old
lacunar infarcts. He was admitted to intensive care unit (ICU). Emergent
ventilator support was used due to dyspnea and respiratory failure. Feverhappened. Sputum culture showed Pseudomonas aeruginosa and carbape-
nem-resistant Acinetobacter baumannii. Urine culture showed Myroides
species, susceptible to imipenem and piperacillin/tazobactum, but resistant
to ceftazidime and ciprofloxacin. Antibiotic was shifted to ceftazidime and
colistin. The patient condition improved gradually under medical treatment
and started weaning trial, but ABG showed CO2 retention. Owing to ventila-
tion dependence and improved condition, he was transferred to the RCW for
long-term care on November 27, 2014.
Conclusion
Serious and prolonged nosocomial outbreaks of urinary tract infections
caused by M. odoratimimus have been reported. Because multiresistance
was generally found in Myroides spp., empirical therapy was usually ineffec-
tive. We report a nosocomial urinary tract infection by Myroides spp.PS 2-336
BETADINE SOLUTION, BETADINE SKIN CLEANSER, BETADINE
SURGICAL SCRUB, AND BETASEPTIC DEMONSTRATED EXCELLENT
VIRUCIDAL IN-VITRO EFFICACY AGAINST EBOLA VIRUS ZAIRE AND
MODIFIED VACCINIA VIRUS ANKARA
Maren Eggers a, Markus Eickmann b, Juergen Zorn c. aLabor Prof. Gisela
Enders MVZ GbR, Stuttgart, Germany; bInstitute for Virology, Philipps
University of Marburg, Marburg, Germany; cMundipharma Research GmbH &
Co.KG, Limburg, Germany
Purpose: The current Ebola virus (EBOV) epidemic highlights the need for
efficacious virucidal products. In Europe, EN 14476:2013/A1:2014 describes
the standard for determining virucidal activity. For the claim ‘virucidal
active against enveloped viruses for hygienic handrub and handwash’ the
Modified vaccinia virus Ankara (MVA) was introduced as reference virus in
2014. In the case of deadly EBOV, which is also an enveloped virus, the ac-
tivity needs to be proven.
The first aim of this study was to test the in-vitro efficacy of four povidone
iodine (PVPI) formulations containing 4% (BETADINE Skin Cleanser), 7.5%
(BETADINE Surgical Scrub), 10% (BETADINE Solution) PVPI and 3.2% PVPI
and 78% alcohol (BETASEPTIC). The second aim was to verify the claimed
concentration-contact-time values with EBOV.
Methods: In accordance with EN 14476 a standard suspension test was used
for testing against MVA and large-volume plating technology for testing
against EBOV to increase test sensitivity and to exclude potential after-ef-
fects. All products were tested under clean (0.3 g/l BSA) and dirty conditions
(3.0 g/l BSA + 3.0 ml/l erythrocytes) as interfering substance with an appli-
cation time of 15, 30, and 60 seconds for MVA and 15 seconds for EBOV. The
products were tested undiluted, 1:10 and 1:100 diluted against MVA and 1:10
diluted against EBOV.
Results: Viral titres of MVA and EBOV were reduced by >99.99% to >99.999%
under clean and dirty conditions with 15 seconds application.
Conclusions: All products showed excellent virucidal efficacy against EBOV
demonstrating the important role PVPI can play in the prevention and
limiting the spread of the Ebola disease. The proven efficacy against both
test viruses with 15 seconds application time is helpful information for
implementation of appropriate guidance to people exposed to EBOV and
confirms excellent virucidal efficacy of PVPI against enveloped viruses.
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CYTOMEGALOVIRUS VIREMIA IN PATIENTS WHO WERE INFECTED WITH
HUMAN IMMUNODEFICIENCY VIRUS
Lin Chai Yi, Shu-Hsing Cheng, Pai-Ling Chang. Department of Laboratory
Medicine & Department of Infection Diseases TaoYuan General Hospital,
Ministry of Health and Welfare, Taiwan
Introduction: At the end of 2014, there were more than 28,000 reported
HIV-infected patients in Taiwan. Cytomegalovirus (CMV) infection, second-
ary to Pneumocystis jeroveci pneumonia and candidiasis, is the 3rd common
opportunistic infections in HIV-infected persons. This study aimed to explore
the relationships between CMV DNA quantitation and the severity of immune
compromised states among HIV patients.
Methods: Real time polymerase chain reaction (RT-PCR) was applied to
detect CMV DNA using COBAS AmpliPrep/COBAS TaqMan CMV assay (Roche
